154 related articles for article (PubMed ID: 33606360)
1. Glycemic benefits with adherence to testosterone therapy in men with hypogonadism and type 2 diabetes mellitus.
Jenkins CR; Rittel A; Sturdivant RX; Wan J; Clerc PG; Manning E; Jenkins LM; Wardian JL; Graybill SD
Andrology; 2021 Jul; 9(4):1076-1085. PubMed ID: 33606360
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hypogonadism with testosterone in patients with type 2 diabetes mellitus.
Gopal RA; Bothra N; Acharya SV; Ganesh HK; Bandgar TR; Menon PS; Shah NS
Endocr Pract; 2010; 16(4):570-6. PubMed ID: 20150021
[TBL] [Abstract][Full Text] [Related]
3. The impact of testosterone replacement therapy on glycemic control, vascular function, and components of the metabolic syndrome in obese hypogonadal men with type 2 diabetes.
Groti K; Žuran I; Antonič B; Foršnarič L; Pfeifer M
Aging Male; 2018 Sep; 21(3):158-169. PubMed ID: 29708829
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Effects of Testosterone Therapy in Men with Type 2 Diabetes and Metabolic Syndrome.
Hackett G
Sex Med Rev; 2019 Jul; 7(3):476-490. PubMed ID: 30803918
[TBL] [Abstract][Full Text] [Related]
5. Effect of Testosterone on Progression From Prediabetes to Diabetes in Men With Hypogonadism: A Substudy of the TRAVERSE Randomized Clinical Trial.
Bhasin S; Lincoff AM; Nissen SE; Wannemuehler K; McDonnell ME; Peters AL; Khan N; Snabes MC; Li X; Li G; Buhr K; Pencina KM; Travison TG
JAMA Intern Med; 2024 Apr; 184(4):353-362. PubMed ID: 38315466
[TBL] [Abstract][Full Text] [Related]
6. Effect of testosterone replacement therapy on sexual function and glycemic control among hypogonadal men with type 2 diabetes mellitus.
Shigehara K; Konaka H; Kato Y; Iijima M; Nakashima K; Kawaguchi S; Nohara T; Izumi K; Namiki M; Mizokami A
Int J Impot Res; 2019 Jan; 31(1):25-30. PubMed ID: 30135606
[TBL] [Abstract][Full Text] [Related]
7. Topical Testosterone Therapy Adherence and Outcomes Among Men With Primary or Secondary Hypogonadism.
Grabner M; Hepp Z; Raval A; Tian F; Khera M
J Sex Med; 2018 Feb; 15(2):148-158. PubMed ID: 29425664
[TBL] [Abstract][Full Text] [Related]
8. Effects of long-term testosterone replacement therapy, with a temporary intermission, on glycemic control of nine hypogonadal men with type 1 diabetes mellitus - a series of case reports.
Saad F; Yassin A; Almehmadi Y; Doros G; Gooren L
Aging Male; 2015; 18(3):164-8. PubMed ID: 26075537
[TBL] [Abstract][Full Text] [Related]
9. Testosterone Therapy and Glucose Homeostasis in Men with Testosterone Deficiency (Hypogonadism).
Saad F
Adv Exp Med Biol; 2017; 1043():527-558. PubMed ID: 29224109
[TBL] [Abstract][Full Text] [Related]
10. Influence of testosterone substitution on glycemic control and endothelial markers in men with newly diagnosed functional hypogonadism and type 2 diabetes mellitus: a randomized controlled trial.
Khripun I; Vorobyev S; Belousov I; Kogan M; Zitzmann M
Aging Male; 2019 Dec; 22(4):241-249. PubMed ID: 30235049
[TBL] [Abstract][Full Text] [Related]
11. Testosterone Therapy in Men With Hypogonadism Prevents Progression From Prediabetes to Type 2 Diabetes: Eight-Year Data From a Registry Study.
Yassin A; Haider A; Haider KS; Caliber M; Doros G; Saad F; Garvey WT
Diabetes Care; 2019 Jun; 42(6):1104-1111. PubMed ID: 30862651
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Age and Comorbidities on the Association Between the Medicare STAR Oral Antihyperglycemic Adherence Metric and Glycemic Control.
Nichols GA; Raebel MA; Dyer W; Schmittdiel JA
J Manag Care Spec Pharm; 2018 Sep; 24(9):856-861. PubMed ID: 30156449
[TBL] [Abstract][Full Text] [Related]
13. Testosterone therapy in diabetes and pre-diabetes.
Corona G; Vena W; Pizzocaro A; Vignozzi L; Sforza A; Maggi M
Andrology; 2023 Feb; 11(2):204-214. PubMed ID: 36542412
[TBL] [Abstract][Full Text] [Related]
14. Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes.
Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P
J Sex Med; 2013 Jun; 10(6):1612-27. PubMed ID: 23551886
[TBL] [Abstract][Full Text] [Related]
15. [Testosterone supplementary therapy for type-2 diabetes mellitus males with hypogonadism: Controversy and analysis].
Cheng Z; Zhang LY; Chen GM; He W; Cai K; Liao ZH
Zhonghua Nan Ke Xue; 2017 Aug; 23(8):739-744. PubMed ID: 29726651
[TBL] [Abstract][Full Text] [Related]
16. Insulin Resistance and Inflammation in Hypogonadotropic Hypogonadism and Their Reduction After Testosterone Replacement in Men With Type 2 Diabetes.
Dhindsa S; Ghanim H; Batra M; Kuhadiya ND; Abuaysheh S; Sandhu S; Green K; Makdissi A; Hejna J; Chaudhuri A; Punyanitya M; Dandona P
Diabetes Care; 2016 Jan; 39(1):82-91. PubMed ID: 26622051
[TBL] [Abstract][Full Text] [Related]
17. Medication adherence and treatment patterns for hypogonadal patients treated with topical testosterone therapy: a retrospective medical claims analysis.
Schoenfeld MJ; Shortridge E; Cui Z; Muram D
J Sex Med; 2013 May; 10(5):1401-9. PubMed ID: 23464534
[TBL] [Abstract][Full Text] [Related]
18. Screening for hypogonadism in diabetes 2008/9: results from the Cheshire Primary Care cohort.
Anderson SG; Heald A; Younger N; Bujawansa S; Narayanan RP; McCulloch A; Jones H
Prim Care Diabetes; 2012 Jul; 6(2):143-8. PubMed ID: 21982717
[TBL] [Abstract][Full Text] [Related]
19. Long-term testosterone therapy in type 2 diabetes is associated with reduced mortality without improvement in conventional cardiovascular risk factors.
Hackett G; Cole N; Mulay A; Strange RC; Ramachandran S
BJU Int; 2019 Mar; 123(3):519-529. PubMed ID: 30216622
[TBL] [Abstract][Full Text] [Related]
20. Testosterone replacement therapy: improved sexual desire and erectile function in men with type 2 diabetes following a 30-week randomized placebo-controlled study.
Hackett G; Cole N; Saghir A; Jones P; Strange RC; Ramachandran S
Andrology; 2017 Sep; 5(5):905-913. PubMed ID: 28771964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
